The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Open accessAbstract
Purpose and ScopeThis guidance provides a data-supported approach to the diagnosis, staging, and treatment of patients diagnosed with hepatocellular carcinoma (HCC).A guidance document is different from a guideline.Guidelines are developed by a multidisciplinary panel of experts who rate the quality (level) of the evidence and the strength of each recommendation using the Grading of Recommendations Assessment, Development, and Evaluation system (GRADE).A guidance document is developed by a panel of experts in the topic, and guidance statements, not recommendations, are put forward to help clinicians understand and implement the most recent evidence.Guidelines for HCC were recently developed according to the GRADE approach.1 The Guidelines for HCC were developed using clinically relevant questions, which were then answered by systematic reviews of the literature, and followed by data-supported recommendations.(2) The Guidelines focused on surveillance, diagnosis, and treatment of HCC.However, some areas of HCC lacked sufficient data to perform systematic reviews, and here the authors will update the 2010 American Association for the Study of Liver Diseases (AASLD) Guidelines, (3) hereto referred as the guidance for HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cheng, B.-Q., Jia, C.-Q., Liu, C.-T., Fan, W., Wang, Q.-L., Zhang, Z.-L., & Yi, C.-H. (2008) · JAMA · doi:10.1001/jama.299.14.1669 · Cited by 190
RetractedCancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Cheng, A.-L., Kang, Y.-K., Chen, Z., Tsao, C.-J., Qin, S., Kim, J. S., Luo, R., Feng, J., Ye, S., Yang, T.-S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70285-7 · Cited by 5,832
Forner, A., Reig, M., & Bruix, J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30010-2 · Cited by 5,531
Kudo, M., Finn, R. S., Qin, S., Han, K.-H., Ikeda, K., Piscaglia, F., Baron, A., Park, J.-W., Han, G., Jassem, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30207-1 · Cited by 5,497
Self-citationEASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
A Model to Predict Survival in Patients With End–Stage Liver Disease
Kamath, P. S., Wiesner, R. H., Malinchoc, M., Kremers, W., Therneau, T. M., Kosberg, C. L., D'Amico, G., Dickson, R. E., & Kim, R. W. (2001) · Hepatology · doi:10.1053/jhep.2001.22172 · Cited by 4,975
El-Khoueiry, A. B., Sangro, B., Yau, T., Crocenzi, T. S., Kudo, M., Hsu, C., Kim, T.-Y., Choo, S.-P., Trojan, J., Welling, T. H., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31046-2 · Cited by 4,280
AASLD guidelines for the treatment of hepatocellular carcinoma
Heimbach, J. K., Kulik, L. M., Finn, R. S., Sirlin, C. B., Abecassis, M. M., Roberts, L. R., Zhu, A. X., Murad, M. H., & Marrero, J. A. (2018) · Hepatology · doi:10.1002/hep.29086 · Cited by 4,070
Self-citationBruix, J., Qin, S., Merle, P., Granito, A., Huang, Y.-H., Bodoky, G., Pracht, M., Yokosuka, O., Rosmorduc, O., Breder, V., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32453-9 · Cited by 3,653
Self-citationLlovet, J. M., Real, M. I., Montaña, X., Planas, R., Coll, S., Aponte, J., Ayuso, C., Sala, M., Muchart, J., Solà, R., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08649-x · Cited by 3,494
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
Chen, C.-J. (2006) · JAMA · doi:10.1001/jama.295.1.65 · Cited by 3,140
Immune Checkpoint Blockade in Cancer Therapy
Postow, M. A., Callahan, M. K., & Wolchok, J. D. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.4358 · Cited by 2,709
Lo, C.-M., Ngan, H., Tso, W.-K., Liu, C.-L., Lam, C.-M., Poon, R. T.-P., Fan, S.-T., & Wong, J. (2002) · Hepatology · doi:10.1053/jhep.2002.33156 · Cited by 2,613
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.014 · Cited by 2,591
Primary liver cancer: Worldwide incidence and trends
Bosch, F. X., Ribes, J., Díaz, M., & Cléries, R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.011 · Cited by 2,477
Laupacis, A., Feeny, D. H., Detsky, A. S., & Tugwell, P. (1992) · Europe PMC (PubMed Central) · Cited by 1,581
Lammer, J., Malagari, K., Vogl, T., Pilleul, F., Denys, A., Watkinson, A., Pitton, M., Sergent, G., Pfammatter, T., Terraz, S., et al. (2010) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-009-9711-7 · Cited by 1,557
Ascha, M. S., Hanouneh, I. A., Lopez, R., Tamimi, T. A.-R., Feldstein, A. F., & Zein, N. N. (2010) · Hepatology · doi:10.1002/hep.23527 · Cited by 1,296
Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma
Yang, H.-I., Lu, S.-N., Liaw, Y.-F., You, S.-L., Sun, C.-A., Wang, L.-Y., Hsiao, C. K., Chen, P.-J., Chen, D.-S., & Chen, C.-J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013215 · Cited by 1,222
Bruix, J., Takayama, T., Mazzaferro, V., Chau, G.-Y., Yang, J., Kudo, M., Cai, J., Poon, R. T., Han, K.-H., Tak, W. Y., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00198-9 · Cited by 1,120
Yoshida, H., Shiratori, Y., Moriyama, M., Arakawa, Y., Ide, T., Sata, M., Inoue, O., Yano, M., Tanaka, M., Fujiyama, S., et al. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-3-199908030-00003 · Cited by 1,096
Clavien, P.-A., Lesurtel, M., Bossuyt, P. M., Gores, G. J., Langer, B., & Perrier, A. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70175-9 · Cited by 1,026
Reig, M., Mariño, Z., Perelló, C., Iñarrairaegui, M., Ribeiro, A., Lens, S., Díaz, A., Vilana, R., Darnell, A., Varela, M., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.008 · Cited by 1,018
Recurrence of Hepatocellular Cancer After Resection: Patterns, Treatments, and Prognosis
Tabrizian, P., Jibara, G., Shrager, B., Schwartz, M., & Roayaie, S. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000000710 · Cited by 903
Poon, R. T.-P., Fan, S. T., Lo, C. M., Liu, C. L., & Wong, J. (2002) · Annals of Surgery · doi:10.1097/00000658-200203000-00009 · Cited by 844
Vilgrain, V., Pereira, H., Assenat, E., Guiu, B., Ilonca, A. D., Pageaux, G.-P., Sibert, A., Bouattour, M., Lebtahi, R., Allaham, W., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30683-6 · Cited by 834
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
Duffy, A. G., Ulahannan, S. V., Makorova-Rusher, O., Rahma, O., Wedemeyer, H., Pratt, D., Davis, J. L., Hughes, M. S., Heller, T., ElGindi, M., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.10.029 · Cited by 819
Singal, A. G., Pillai, A., & Tiro, J. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001624 · Cited by 817
White, D. L., Kanwal, F., & El–Serag, H. B. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.10.001 · Cited by 766
Marrero, J. A., Feng, Z., Wang, Y., Nguyen, M. H., Befeler, A. S., Roberts, L. R., Reddy, K. R., Harnois, D., Llovet, J. M., Normolle, D., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.005 · Cited by 745
Self-citationPepe, M. S., Feng, Z., Janes, H., Bossuyt, P. M., & Potter, J. D. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn326 · Cited by 717
Yau, T., Tang, V. Y. F., Yao, T.-J., Fan, S.-T., Lo, C.-M., & Poon, R. T. P. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.032 · Cited by 698
Lencioni, R., Llovet, J. M., Han, G., Tak, W. Y., Yang, J., Guglielmi, A., Paik, S. W., Reig, M., Kim, D. Y., Chau, G.-Y., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.012 · Cited by 694
Salem, R., Gordon, A. C., Mouli, S., Hickey, R., Kallini, J., Gabr, A., Mulcahy, M. F., Baker, T., Abecassis, M., Miller, F. H., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.08.029 · Cited by 691
Self-citationOral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review
Falade-Nwulia, O., Suarez-Cuervo, C., Nelson, D. R., Fried, M. W., Segal, J. B., & Sulkowski, M. S. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2575 · Cited by 688
Chow, P. K. H., Gandhi, M., Tan, S.-B., Khin, M. W., Khasbazar, A., Ong, J., Choo, S. P., Cheow, P. C., Chotipanich, C., Lim, K., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.0892 · Cited by 658
Salem, R., Lewandowski, R. J., Kulik, L., Wang, E., Riaz, A., Ryu, R. K., Sato, K. T., Gupta, R., Nikolaidis, P., Miller, F. H., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.049 · Cited by 650
Self-citationPrognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort†
Marrero, J. A., Fontana, R. J., Barrat, A., Askari, F., Conjeevaram, H. S., Su, G. L., & Lok, A. S. (2005) · Hepatology · doi:10.1002/hep.20636 · Cited by 637
Self-citationEpidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Massarweh, N. N., & El-Serag, H. B. (2017) · Cancer Control · doi:10.1177/1073274817729245 · Cited by 634
Alcohol and hepatocellular carcinoma
Morgan, T. R., Mandayam, S., & Jamal, M. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.020 · Cited by 625
Des-γ-Carboxy (Abnormal) Prothrombin as a Serum Marker of Primary Hepatocellular Carcinoma
Liebman, H. A., Furie, B. C., Tong, M. J., Blanchard, R. A., Lo, K.-J., Lee, S.-D., Coleman, M. S., & Furie, B. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405313102204 · Cited by 617
Ioannou, G. N., Green, P. K., & Berry, K. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.08.030 · Cited by 573
Wahl, D. R., Stenmark, M. H., Tao, Y., Pollom, E. L., Caoili, E. M., Lawrence, T. S., Schipper, M. J., & Feng, M. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.4925 · Cited by 567
Local-Regional Treatment of Hepatocellular Carcinoma
Lencioni, R., & Crocetti, L. (2012) · Radiology · doi:10.1148/radiol.11110144 · Cited by 514
Users' Guides to the Medical Literature: V. How to Use an Article About Prognosis
Laupacis, A. (1994) · JAMA · doi:10.1001/jama.1994.03520030076032 · Cited by 502
Waziry, R., Hajarizadeh, B., Grebely, J., Amin, J., Law, M., Danta, M., George, J., & Dore, G. J. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.025 · Cited by 500
Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta‐analysis
Roberts, L. R., Sirlin, C. B., Zaiem, F., Almasri, J., Prokop, L. J., Heimbach, J. K., Murad, M. H., & Mohammed, K. (2018) · Hepatology · doi:10.1002/hep.29487 · Cited by 497
Self-citationYao, F. Y., Mehta, N., Flemming, J., Dodge, J., Hameed, B., Fix, O., Hirose, R., Fidelman, N., Kerlan, R. K., & Roberts, J. P. (2015) · Hepatology · doi:10.1002/hep.27752 · Cited by 485
Burrel, M., Reig, M., Forner, A., Barrufet, M., Lope, C. R. D., Tremosini, S., Ayuso, C., Llovet, J. M., Real, M. I., & Bruix, J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.01.008 · Cited by 485
Cho, Y. K., Kim, J. K., Kim, M. Y., Rhim, H., & Han, J. K. (2009) · Hepatology · doi:10.1002/hep.22648 · Cited by 466
N'Kontchou, G., Mahamoudi, A., Aout, M., Ganne-Carrié, N., Grando, V., Coderc, E., Vicaut, E., Trinchet, J. C., Sellier, N., Beaugrand, M., et al. (2009) · Hepatology · doi:10.1002/hep.23181 · Cited by 450
Sala, M., Llovet, J. M., Vilana, R., Bianchi, L., Solé, M., Ayuso, C., Brú, C., & Bruix, J. (2004) · Hepatology · doi:10.1002/hep.20465 · Cited by 447
Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030
Petrick, J. L., Kelly, S. P., Altekruse, S. F., McGlynn, K. A., & Rosenberg, P. S. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.7412 · Cited by 442
Pathogenesis of hepatitis B virus—related hepatocellular carcinoma: Old and new paradigms
Bréchot, C. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.016 · Cited by 438
Prospective validation of the Barcelona Clinic Liver Cancer staging system
Cillo, U., Vitale, A., Grigoletto, F., Farinati, F., Brolese, A., Zanus, G., Neri, D., Boccagni, P., Srsen, N., D'Amico, F., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.12.015 · Cited by 425
Gupta, S., Bent, S., & Kohlwes, J. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-1-200307010-00012 · Cited by 420
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.045 · Cited by 419
Mehta, N., Heimbach, J., Harnois, D. M., Sapisochin, G., Dodge, J. L., Lee, D., Burns, J. M., Sanchez, W., Greig, P. D., Grant, D. R., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5116 · Cited by 398
Self-citationSarasin, F. P., Giostra, E., & Hadengue, A. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00197-0 · Cited by 368
Ravaioli, M., Grazi, G. L., Piscaglia, F., Trevisani, F., Cescon, M., Ercolani, G., Vivarelli, M., Golfieri, R., D’Errico Grigioni, A., Panzini, I., et al. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02409.x · Cited by 363
Wald, C., Russo, M. W., Heimbach, J. K., Hussain, H. K., Pomfret, E. A., & Bruix, J. (2013) · Radiology · doi:10.1148/radiol.12121698 · Cited by 363
Self-citationKim, S. Y., An, J., Lim, Y.-S., Han, S., Lee, J.-Y., Byun, J. H., Won, H. J., Lee, S. J., Lee, H. C., & Lee, Y. S. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.3147 · Cited by 356
Kudo, M., Han, G., Finn, R. S., Poon, R. T. P., Blanc, J.-F., Yan, L., Yang, J., Lu, L., Tak, W.-Y., Yu, X., et al. (2014) · Hepatology · doi:10.1002/hep.27290 · Cited by 355
Self-citationJohnson, P. J., Pirrie, S. J., Cox, T. F., Berhane, S., Teng, M., Palmer, D., Morse, J., Hull, D., Patman, G., Kagebayashi, C., et al. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0870 · Cited by 350
Kuper, H., Tzonou, A., Kaklamani, E., Hsieh, C.-C., Lagiou, P., Adami, H.-O., Trichopoulos, D., & Stuver, S. O. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000215)85:4<498::aid-ijc9>3.0.co;2-f · Cited by 350
Sieghart, W., Hucke, F., Pinter, M., Graziadei, I., Vogel, W., Müller, C., Heinzl, H., Trauner, M., & Peck-Radosavljevic, M. (2013) · Hepatology · doi:10.1002/hep.26256 · Cited by 343
International trends in liver cancer incidence, overall and by histologic subtype, 1978–2007
Petrick, J. L., Braunlin, M., Laversanne, M., Valery, P. C., Bray, F., & McGlynn, K. A. (2016) · International Journal of Cancer · doi:10.1002/ijc.30211 · Cited by 342
Population-Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States
Welzel, T. M., Graubard, B. I., Quraishi, S., Zeuzem, S., Davila, J. A., El-Serag, H. B., & McGlynn, K. A. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.160 · Cited by 328
Simmons, O., Fetzer, D. T., Yokoo, T., Marrero, J. A., Yopp, A., Kono, Y., Parikh, N. D., Browning, T., & Singal, A. G. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13841 · Cited by 328
Self-citationTang, A., Bashir, M. R., Corwin, M. T., Cruite, I., Dietrich, C. F., Do, R. K. G., Ehman, E. C., Fowler, K. J., Hussain, H. K., Jha, R. C., et al. (2018) · Radiology · doi:10.1148/radiol.2017170554 · Cited by 319
Self-citationRadioembolization for hepatocellular carcinoma
Sangro, B., Iñarrairaegui, M., & Bilbao, J. I. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.07.012 · Cited by 315
Germani, G., Pleguezuelo, M., Gurusamy, K., Meyer, T., Isgrò, G., & Burroughs, A. K. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.12.004 · Cited by 304
Sapisochin, G., Barry, A., Doherty, M., Fischer, S., Goldaracena, N., Rosales, R., Russo, M., Beecroft, R., Ghanekar, A., Bhat, M., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.022 · Cited by 301
Mandorfer, M., Kozbial, K., Schwabl, P., Freissmuth, C., Schwarzer, R., Stern, R., Chromy, D., Stättermayer, A. F., Reiberger, T., Beinhardt, S., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.027 · Cited by 299
Recurrence After Liver Transplantation for Hepatocellular Carcinoma: A New MORAL to the Story
Halazun, K. J., Najjar, M., Abdelmessih, R. M., Samstein, B., Griesemer, A. D., Guarrera, J. V., Kato, T., Verna, E. C., Emond, J. C., & Brown, R. S. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000001966 · Cited by 281
Kawamura, Y., Arase, Y., Ikeda, K., Seko, Y., Imai, N., Hosaka, T., Kobayashi, M., Saitoh, S., Sezaki, H., Akuta, N., et al. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.327 · Cited by 280 · cited 1×
“In a large Japanese study, those with NAFLD and AF had a 25-fold increase in development of HCC compared to those without fibrosis.(45) The best available evidence suggests that NAFLD-related cirrhosis is a risk factor for HCC, but at a lower rate compared to HCVrelated cirrhosis though the annual incidence rate in no…”
BackgroundCancer risk in patients with hereditary hemochromatosis and in their first-degree relatives
Elmberg, M., Hultcrantz, R., Ekbom, A., Brandt, L., Olsson, S., Olsson, R., Lindgren, S., Lööf, L., Stål, P., Wallerstedt, S., et al. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.035 · Cited by 273 · cited 2×
“9%.(51) In a recent systematic review, a total of 6,528 patients with autoimmune hepatitis (AIH) had a median follow-up of 8 years were evaluated for HCC incidence.”
BackgroundLiver transplantation for hepatocellular cancer: The impact of the MELD allocation policy
Wiesner, R. H., Freeman, R. B., & Mulligan, D. C. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.040 · Cited by 273
Improving liver allocation: MELD and PELD
Freeman, R. B., Wiesner, R. H., Roberts, J. P., McDiarmid, S., Dykstra, D. M., & Merion, R. M. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6135.2004.00403.x · Cited by 270
Atiq, O., Tiro, J., Yopp, A. C., Muffler, A., Marrero, J. A., Parikh, N. D., Murphy, C., McCallister, K., & Singal, A. G. (2017) · Hepatology · doi:10.1002/hep.28895 · Cited by 266
Self-citationTakahara, T., Wakabayashi, G., Beppu, T., Aihara, A., Hasegawa, K., Gotohda, N., Hatano, E., Tanahashi, Y., Mizuguchi, T., Kamiyama, T., et al. (2015) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.276 · Cited by 263
Thirty-Year Outcomes of the National Hepatitis B Immunization Program in Taiwan
Chiang, C.-J., Yang, Y.-W., You, S.-L., Lai, M.-S., & Chen, C.-J. (2013) · JAMA · doi:10.1001/jama.2013.276701 · Cited by 247
Hepatocellular Carcinoma Patients Are Advantaged in the Current Liver Transplant Allocation System
Washburn, K., Edwards, E., Harper, A., & Freeman, R. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03127.x · Cited by 245
Yopp, A. C., Mansour, J. C., Beg, M. S., Arenas, J., Trimmer, C., Reddick, M., Pedrosa, I., Khatri, G., Yakoo, T., Meyer, J. J., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3413-8 · Cited by 242
Self-citationCheung, T. T., Poon, R. T. P., Yuen, W. K., Chok, K. S. H., Jenkins, C. R., Chan, S. C., Fan, S. T., & Lo, C. M. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e31827b947a · Cited by 236
Sun, C.-A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg041 · Cited by 234
Singal, A. G., Nehra, M., Adams-Huet, B., Yopp, A. C., Tiro, J. A., Marrero, J. A., Lok, A. S., & Lee, W. M. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.449 · Cited by 225
Self-citationFacciorusso, A., Di Maso, M., & Muscatiello, N. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.02.005 · Cited by 209
Nakagawa, S., Wei, L., Song, W. M., Higashi, T., Ghoshal, S., Kim, R. S., Bian, C. B., Yamada, S., Sun, X., Venkatesh, A., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.11.004 · Cited by 205
Tremosini, S., Forner, A., Boix, L., Vilana, R., Bianchi, L., Reig, M., Rimola, J., Rodríguez-Lope, C., Ayuso, C., Solé, M., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301862 · Cited by 188
Poon, R. T. P., Fan, S. T., Lo, C. M., Liu, C. L., & Wong, J. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000225255.01668.65 · Cited by 171
Kolligs, F. T., Bilbao, J. I., Jakobs, T., Iñarrairaegui, M., Nagel, J. M., Rodriguez, M., Haug, A., D'Avola, D., op den Winkel, M., Martinez‐Cuesta, A., et al. (2015) · Liver International · doi:10.1111/liv.12750 · Cited by 171
Lin, O. S., Keeffe, E. B., Sanders, G. D., & Owens, D. K. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01963.x · Cited by 168
Personalized treatment of patients with very early hepatocellular carcinoma
Vitale, A., Peck-Radosavljevic, M., Giannini, E. G., Vibert, E., Sieghart, W., Van Poucke, S., & Pawlik, T. M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.09.012 · Cited by 168
Moreno-Luna, L. E., Yang, J. D., Sánchez, W., Paz‐Fumagalli, R., Harnois, D. M., Mettler, T. A., Gansen, D. N., de Groen, P. C., Lazaridis, K. N., Menon, K. V., et al. (2012) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-012-0481-2 · Cited by 147
Self-citationBesa, C., Lewis, S. C., Pandharipande, P. V., Chhatwal, J., Kamath, A., Cooper, N., Knight‐Greenfield, A., Babb, J. S., Boffetta, P., Padrón, N. A., et al. (2016) · Abdominal Radiology · doi:10.1007/s00261-016-0841-5 · Cited by 147
Self-citationBush, D. A., Smith, J. C., Slater, J. D., et al. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.02.027 · Cited by 146
Chen, J., Zaidi, S., Rao, S., Chen, J., Phan, L. M., Farci, P., Su, X., Shetty, K., White, J. C., Zamboni, F., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.09.007 · Cited by 145
The Challenge of Prognosis and Staging for Hepatocellular Carcinoma
Marrero, J. A., Kudo, M., & Bronowicki, J. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-s4-23 · Cited by 144
Self-citationLeerapun, A., Suravarapu, S. V., Bida, J. P., Clark, R. J., Sanders, E. L., Mettler, T. A., Stadheim, L. M., Aderca, I., Moser, C. D., Nagorney, D. M., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.12.005 · Cited by 138
Self-citationMarks, R. M., Ryan, A., Heba, E. R., Tang, A., Wolfson, T. J., Gamst, A. C., Sirlin, C. B., & Bashir, M. R. (2015) · American Journal of Roentgenology · doi:10.2214/ajr.14.12986 · Cited by 137
Self-citationKelley, R. K., Verslype, C., Cohn, A. L., Yang, T.-S., Su, W., Burris, H. A., Braiteh, F., Vogelzang, N. J., Spira, A. I., Foster, P., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdw651 · Cited by 137
Leung, C., Yeoh, S. W., Patrick, D., Ket, S., Marion, K., Gow, P., & Angus, P. W. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i4.1189 · Cited by 131
Schnadig, I. D., Fromme, E. K., Loprinzi, C. L., Sloan, J. A., Mori, M., Li, H., & Beer, T. M. (2008) · Cancer · doi:10.1002/cncr.23856 · Cited by 120
Geschwind, J.-F. H., Kudo, M., Marrero, J. A., Venook, A. P., Chen, X., Bronowicki, J., Dagher, L., Furuse, J., de Guevara, L. L., Papandreou, C. N., et al. (2016) · Radiology · doi:10.1148/radiol.2015150667 · Cited by 120
Self-citationLu, Z., Wen, F., Guo, Q., Liang, H., Mao, X., & Sun, H. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32835a0a07 · Cited by 117
Loomba, R. S., Liu, J. B., Yang, H., Lee, M., Lu, S., Wang, L., Iloeje, U. H., You, S., Brenner, D. A., & Chen, C. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.04.043 · Cited by 114
Perumpail, R. B., Wong, R. J., Ahmed, A., & Harrison, S. A. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3821-7 · Cited by 111
Palavecino, M. E., Chun, Y. S., Madoff, D. C., et al. (2009) · Surgery · doi:10.1016/j.surg.2008.10.009 · Cited by 110
Lencioni, R. A., de Baère, T., Martin, R. C. G., Nutting, C. W., & Narayanan, G. (2015) · Liver Cancer · doi:10.1159/000367747 · Cited by 110
Gramenzi, A., Golfieri, R., Mosconi, C., Cappelli, A., Granito, A., Cucchetti, A., Marinelli, S., Pettinato, C., Erroi, V., Fiumana, S., et al. (2014) · Liver International · doi:10.1111/liv.12574 · Cited by 109
Plasma Des–γ–Carboxyprothrombin in the Early Stage of Hepatocellular Carcinoma
Tsai, S., Huang, G., Yang, P., Sheu, J., Sung, J., & Chen, D. (1990) · Hepatology · doi:10.1002/hep.1840110321 · Cited by 107
Tansel, A., Katz, L. H., El‐Serag, H. B., Thrift, A. P., Parepally, M., Shakhatreh, M. H., & Kanwal, F. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.02.006 · Cited by 106
Abou‐Alfa, G. K., Meyer, T., Cheng, A., El-Khoueiry, A. B., Rimassa, L., Ryoo, B., Çiçin, İ., Merle, P., Park, J., Blanc, J., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.36.4_suppl.207 · Cited by 100
Masuzaki, R., Tateishi, R., Yoshida, H., Yoshida, H., Sato, S., Kato, N., Kanai, F., Sugioka, Y., Ikeda, H., Shiina, S., et al. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318050074f · Cited by 99
Tayob, N., Lok, A. S.-F., Do, K.-A., & Feng, Z. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.049 · Cited by 98
Tanabe, M., Kanki, A., Wolfson, T. J., Costa, E. A. C., Mamidipalli, A., Ferreira, M. P. F. D., Santillan, C., Middleton, M. S., Gamst, A. C., Kono, Y., et al. (2016) · Radiology · doi:10.1148/radiol.2016152173 · Cited by 98
Self-citationDenys, A. L., Lacombe, C., Schneider, F., Madoff, D. C., Doenz, F., Qanadli, S. D., Halkic, N., Sauvanet, A., Vilgrain, V., & Schnyder, P. A. (2005) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000182183.28547.dc · Cited by 95
Mitra, A., Satelli, A., Xia, X., Cutrera, J., Mishra, L., & Li, S. (2014) · International Journal of Cancer · doi:10.1002/ijc.29382 · Cited by 89
The meaning of life expectancy
Naimark, D. M. J., Naglie, G., & Detsky, A. S. (1994) · Journal of General Internal Medicine · doi:10.1007/bf02599016 · Cited by 89
Cabozantinib: A MET, RET, and VEGFR2 Tyrosine Kinase Inhibitor
Grüllich, C. (2014) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-54490-3_12 · Cited by 83
King, L. Y., Canasto‐Chibuque, C., Johnson, K. B., Yip, S. H., Chen, X., Kojima, K., Deshmukh, M., Venkatesh, A., Tan, P. S., Sun, X., et al. (2014) · Gut · doi:10.1136/gutjnl-2014-307862 · Cited by 80
Chen, Q.-W., Ying, H.-F., Gao, S., Shen, Y.-H., Meng, Z.-Q., Chen, H., Chen, Z., & Teng, W.-J. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.07.008 · Cited by 79
Choi, S. H., Byun, J. H., Kim, S. Y., Lee, S. J., Won, H. J., Shin, Y. M., & Kim, P. N. (2016) · Investigative Radiology · doi:10.1097/rli.0000000000000258 · Cited by 77
Chen, C., Hu, F.-C., Huang, G., Lee, P., Tsang, Y.-M., Cheng, A., Chen, D., Wang, J., & Sheu, J. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.12.025 · Cited by 74
Kim, Y., An, C., Kim, S., & Kim, M. (2017) · European Radiology · doi:10.1007/s00330-017-5188-y · Cited by 74
Goodgame, B., Shaheen, N. J., Galanko, J., & El-Serag, H. B. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07678.x · Cited by 72
Facciorusso, A., Serviddio, G., & Muscatiello, N. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i18.770 · Cited by 72
Chen, I., Ariizumi, S., Nakano, M., & Yamamoto, M. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0793-2 · Cited by 65
de Haas, R. J., Lim, C., Bhangui, P., Salloum, C., Compagnon, P., Feray, C., Calderaro, J., Luciani, A., & Azoulay, D. (2018) · Hepatology · doi:10.1002/hep.29468 · Cited by 65
Shehta, A., Han, H., Yoon, Y., Cho, J. Y., & Choi, Y. (2015) · Surgical Endoscopy · doi:10.1007/s00464-015-4253-3 · Cited by 64
Matsumoto, T., Takai, A., Eso, Y., Kinoshita, K., Manabe, T., Seno, H., Chiba, T., & Marusawa, H. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1800 · Cited by 63
Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?
Lok, A. S.-F. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06576.x · Cited by 58
Taouli, B. A., Hoshida, Y., Kakite, S., Chen, X., Tan, P. S., Sun, X., Kihira, S., Kojima, K., Toffanin, S., Fiel, M. I., et al. (2017) · European Radiology · doi:10.1007/s00330-017-4844-6 · Cited by 55
Duarte‐Salles, T., Misra, S. K., Stępień, M., Plymoth, A., Muller, D. C., Overvad, K., Olsen, A., Tjønneland, A. M., Baglietto, L., Severi, G., et al. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0434 · Cited by 54
XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance
Yang, S., & Wang, X. Q. (2017) · BMC Cancer · doi:10.1186/s12885-017-3345-y · Cited by 51
Grazioli, L., Ambrosini, R., Frittoli, B., Grazioli, M., & Morone, M. (2017) · European Journal of Radiology · doi:10.1016/j.ejrad.2017.08.028 · Cited by 50
Sohn, J. H., Durán, R., Zhao, Y., Fleckenstein, F. N., Chapiro, J., Sahu, S., Schernthaner, R. E., Qian, T., Lee, H., Li, Z., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.10.036 · Cited by 45
White, D. L., Richardson, P., Tayoub, N., Davila, J. A., Kanwal, F., & El‐Serag, H. B. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.10.004 · Cited by 41
Basha, M. A. A., Sammak, D. A. E. A. E., & Sammak, A. A. E. (2017) · Clinical Radiology · doi:10.1016/j.crad.2017.05.019 · Cited by 40
Screening and Surveillance of Hepatocellular Carcinoma
Fetzer, D. T., Rodgers, S. K., Harris, A. C., Kono, Y., Wasnik, A. P., Kamaya, A., & Sirlin, C. B. (2017) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2017.06.012 · Cited by 40
Self-citationAccuracy of the diagnostic evaluation of hepatocellular carcinoma with LI-RADS
Liu, W., Qin, J., Guo, R., Xie, S., Jiang, H., Wang, X., Kang, Z., Wang, J., & Shan, H. (2017) · Acta Radiologica · doi:10.1177/0284185117716700 · Cited by 36
Pok, S., Barn, V., Wong, H. J., et al. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13232 · Cited by 33
Cited by
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma
Finn, R. S., Qin, S., Ikeda, M., Galle, P. R., Ducreux, M., Kim, T.-Y., Kudo, M., Breder, V., Merle, P., Kaseb, A. O., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915745 · Cited by 7,470
Self-citationLlovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00240-3 · Cited by 7,055
Self-citationVillanueva, A. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1713263 · Cited by 4,508
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Yang, J. D., Hainaut, P., Gores, G. J., Amadou, A., Plymoth, A., & Roberts, L. R. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0186-y · Cited by 4,228
Self-citationRinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667
Metadata
- Authors
- Marrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., & Heimbach, J. K.
- Venue
- Hepatology
- Published
- 2018-08
- Volume
- 68
- Issue
- 2
- Pages
- 723-750
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W2796067155
- Cited by
- 4,539
- References
- 149
- FWCI
- 223.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.